Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript March 9, 2024 Oncolytics Biotech Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to Oncolytics Biotech’s Fourth Quarter and Full Year 2023 Conference Call. All participants […]

Related Keywords

Germany , Canada , United States , San Diego , California , Canadian , American , German , Allison Hagerman , Pat Andrews , Matt Coffey , Tom Heineman , Product Development , Pancreatic Cancer Action Network , Pfizer , American Cancer Society , Oncolytics Biotech , Global Coalition For Adaptive Research , Manufacturing Organization , Contract Development , Chief Executive Officer , Chief Financial Officer , Kirk Look , Chief Medical Officer , Vice President , Pancreatic Ductal Adenocarcinoma , Global Coalition , Adaptive Research , Investor Relations , New Year , Wall Street Picked These , Pancreatic Cancer , Oncolytics Biotech Inc , Breast Cancer , Fourth Quarter , Financial Results , Adrenal Cancer , Colorectal Cancer , Poblet , Manufacturing ,